Ana Gorosquieta

536 total citations
9 papers, 58 citations indexed

About

Ana Gorosquieta is a scholar working on Genetics, Epidemiology and Infectious Diseases. According to data from OpenAlex, Ana Gorosquieta has authored 9 papers receiving a total of 58 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Ana Gorosquieta's work include Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Antifungal resistance and susceptibility (2 papers). Ana Gorosquieta is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Antifungal resistance and susceptibility (2 papers). Ana Gorosquieta collaborates with scholars based in Spain, Brazil and Italy. Ana Gorosquieta's co-authors include Idoya Lahortiga, María D. Odero, María José Larráyoz, Iria Vázquez, Xabier Agirre, J.L. Vizmanos, Juan C. Cigudosa, Katy Perez‐Equiza, F. Sala and Marı́a José Calasanz and has published in prestigious journals such as Blood, Biology of Blood and Marrow Transplantation and Cancer Genetics and Cytogenetics.

In The Last Decade

Ana Gorosquieta

8 papers receiving 55 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana Gorosquieta Spain	4	27	22	12	10	8	9	58
Maxi Wass Germany	4	15 0.6×	30 1.4×	10 0.8×	13 1.3×	18 2.3×	7	74
Mariella D’Angiò Italy	5	12 0.4×	10 0.5×	5 0.4×	5 0.5×	15 1.9×	8	57
Shaimaa El‐Ashwah Egypt	4	10 0.4×	19 0.9×	7 0.6×	8 0.8×	3 0.4×	31	55
Yotam Bronstein Israel	4	14 0.5×	11 0.5×	19 1.6×	4 0.4×	29 3.6×	12	63
José Refugio Torres‐Nava Mexico	6	18 0.7×	14 0.6×	5 0.4×	22 2.2×	4 0.5×	9	68
Sæmundur Rögnvaldsson Iceland	5	23 0.9×	31 1.4×	20 1.7×	2 0.2×	2 0.3×	17	61
Thomas Chalopin France	5	19 0.7×	19 0.9×	7 0.6×	6 0.6×	5 0.6×	20	54
Martin Schrappe Germany	4	19 0.7×	25 1.1×	5 0.4×	56 5.6×	3 0.4×	6	81
Rose‐Marie Hamladji France	6	7 0.3×	60 2.7×	20 1.7×	21 2.1×	2 0.3×	12	78
R Mataix Spain	3	7 0.3×	24 1.1×	8 0.7×	10 1.0×	3 0.4×	8	34

Countries citing papers authored by Ana Gorosquieta

Since Specialization

Citations

This map shows the geographic impact of Ana Gorosquieta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Gorosquieta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Gorosquieta more than expected).

Fields of papers citing papers by Ana Gorosquieta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Gorosquieta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Gorosquieta. The network helps show where Ana Gorosquieta may publish in the future.

Co-authorship network of co-authors of Ana Gorosquieta

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Gorosquieta. A scholar is included among the top collaborators of Ana Gorosquieta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Gorosquieta. Ana Gorosquieta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Gorosquieta, Ana, et al.. (2016). Chronic Neutrophilic Leukemia. Elsevier eBooks. 40(6). 5–12. 1 indexed citations

2.

Pozo, José Luís del, et al.. (2015). Antifungal prophylaxis with anidulafungin to minimize drug interactions with an antiepileptic treatment in a hematopoietic stem cell transplant recipient. Journal of Clinical Pharmacy and Therapeutics. 40(5). 601–603. 2 indexed citations

3.

Lozano, Sara, et al.. (2014). High Mortality Associated with Neurological Complications after Allogeneic Stem Cell Transplantation. Blood. 124(21). 5843–5843.

4.

Gorosquieta, Ana, et al.. (2013). Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review. Therapeutic Advances in Hematology. 4(3). 217–230. 8 indexed citations

5.

Ramírez, Natalia, et al.. (2013). Monitoring CMV-Specific CD8+ T-Cell Responses After Allogeneic Stem Cell Transplantation: A New Way of Guiding Anti-Viral Therapy. Biology of Blood and Marrow Transplantation. 19(2). S207–S207. 1 indexed citations

6.

Micucci, Carla, Idoya Lahortiga, Patrizia Gasparini, et al.. (2006). A novel t(2;3)(p11;q27) in a case of follicular lymphoma. Cancer Genetics and Cytogenetics. 172(1). 70–73. 1 indexed citations

7.

Zazpe, Idoya, et al.. (2005). Linfoma cerebral primario: revisión bibliográfica y experiencia en el Hospital de Navarra en los últimos 5 años (2000-2004). Anales del Sistema Sanitario de Navarra. 28(3). 367–77. 8 indexed citations

8.

Lahortiga, Idoya, J.L. Vizmanos, Xabier Agirre, et al.. (2003). NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15).. PubMed. 63(12). 3079–83. 33 indexed citations

9.

Gorosquieta, Ana, et al.. (1996). [Asymptomatic pathological rupture of the spleen as the presenting form of acute lymphoblastic leukemia].. PubMed. 41(3). 261–2. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact